Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-16-077386
Filing Date
2016-01-27
Accepted
2016-01-27 21:38:30
Documents
2
Period of Report
2016-01-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v429895_4.html 4  
1 OWNERSHIP DOCUMENT v429895_4.xml 4 5695
2 POWER OF ATTORNEY v429895_ex24.htm EX-24 9036
  Complete submission text file 0001144204-16-077386.txt   16400
Mailing Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170 212-584-4171
Caladrius Biosciences, Inc. (Issuer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8090 Services-Misc Health & Allied Services, NEC

Mailing Address 305 COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address
BERMAN RICHARD J (Reporting) CIK: 0001111620 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33650 | Film No.: 161366454